CareLit Fachartikel
The Smalland Medium-sized Enterprises Office (SME Office) at the European Medicines Agency
Carr, M. · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · 2009 · Heft 11 · S. 20 bis 23
Dokument
344668
CareLit-ID
Jahr
2009
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
On 15 December 2005, the European Medicines Agency (EMEA) launched an “SME Office” to provide financial and administrative assistance to micro-, smalland medium-sized enterprises (SMEs), with the aim of promoting innovation and the development of new human and veterinary medicinal products by SMEs. According to current EU definition of an SME, companies with fewer than 250 employees, and an annual turnover of not more than €50 million or an annual balance sheet total of not more than €43 million, are eligible for assistance from the SME Office. Incentives available from the EMEA for SMEs, include: At the end of…
Schlagworte
KMU
EMEA
Arzneimittel
Innovation
finanzielle Unterstützung
regulatorische Beratung
Small and Medium-Sized Enterprises
Drug Approval
Veterinary Medicine
Human Medicine
Financial Support
Regulatory Affairs
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
